2月20日 - ** 制药商旺达制药公司VNDA.O的股票在延时交易中上涨34.7%，至7.77美元
** 美国FDA批准该公司的抗精神病药物Bysanti上市
** 旨在治疗精神分裂症和急性双相情感障碍的药物
** 批准该药的同时，FDA 提出了最严重的警告，即老年痴呆症相关精神病患者的死亡风险增加
** 2025 年股价上涨 84.1%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.